{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:18:20Z","timestamp":1787008700503,"version":"build-2736575974"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011727","name":"Stockholm County Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["975207"],"award-info":[{"award-number":["975207"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"publisher","award":["2020-02014"],"award-info":[{"award-number":["2020-02014"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"publisher","award":["2022-01428"],"award-info":[{"award-number":["2022-01428"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"publisher","award":["#2022-01428"],"award-info":[{"award-number":["#2022-01428"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"publisher","award":["2022-01425"],"award-info":[{"award-number":["2022-01425"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johanniterorden"},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["963369"],"award-info":[{"award-number":["963369"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["1002840"],"award-info":[{"award-number":["1002840"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["M22-0170"],"award-info":[{"award-number":["M22-0170"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"CIMED","doi-asserted-by":"publisher","award":["M24-0221"],"award-info":[{"award-number":["M24-0221"]}],"id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Cholinesterase inhibitors (ChEIs) have beneficial effects on the heart. Associations between ChEI-use and reduced mortality and cardiovascular events in Alzheimer's disease (AD) have been shown. Whether these associations exist in those with both heart failure (HF) and AD is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A propensity score (PS) matched cohort with patients with HF and AD was obtained through linking registers for cognitive\/dementia disorders, comorbidities, drug prescription, and death, in Sweden, to analyse associations between ChEI-use and risk of mortality or hospitalization for HF, stroke, or myocardial infarction, were examined. In 455 patients with and 455 without ChEI treatment, ChEI use was associated with reductions of mortality and hospitalization due to HF by 21% [0.79; (confidence interval) CI 0.66\u20130.96] and 47% (0.53; CI 0.38\u20130.75), respectively. Donepezil and galantamine but not rivastigmine were associated with a lower risk of death compared with non-users. Donepezil was associated with a lower risk of hospitalization due to HF compared with non-users. There was no significant difference in hospitalization for bradycardia, AV block, or implantation of pacemaker between ChEI use and non-use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that in persons with HF and AD, treatment with ChEIs is associated with improved survival and a decreased risk of hospital care for HF, but results due to the type of ChEI vary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcvp\/pvae091","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T07:27:20Z","timestamp":1734334040000},"page":"22-33","source":"Crossref","is-referenced-by-count":9,"title":["Cholinesterase inhibitors and reduced risk of hospitalization and mortality in patients with Alzheimer's dementia and heart failure"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-116X","authenticated-orcid":false,"given":"Marianne","family":"Reimers-Wessberg","sequence":"first","affiliation":[{"name":"Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet , Alfred Nobels all\u00e9 8, 171 77 Stockholm ,","place":["Sweden"]},{"name":"Research and Development Unit, Stockholms Sjukhem , 112 19 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7266-3431","authenticated-orcid":false,"given":"Hong","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet , Alfred Nobels all\u00e9 8, 171 77 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Fastbom","sequence":"additional","affiliation":[{"name":"Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet , 171 65 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"Seiger","sequence":"additional","affiliation":[{"name":"Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet , Alfred Nobels all\u00e9 8, 171 77 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eriksdotter","sequence":"additional","affiliation":[{"name":"Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet , Alfred Nobels all\u00e9 8, 171 77 Stockholm ,","place":["Sweden"]},{"name":"Theme Inflammation and Aging, Department of Aging, Karolinska University Hospital , 141 86 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025020804504594600_bib1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer's disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"2025020804504594600_bib2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"2025020804504594600_bib3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"2025020804504594600_bib4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.0b013e3181b59bf3","article-title":"Treatment of vascular risk factors is associated with slower decline in Alzheimer disease","volume":"73","author":"Deschaintre","year":"2009","journal-title":"Neurology"},{"key":"2025020804504594600_bib5","first-page":"464","article-title":"Aging and the autonomic nervous system","volume":"5","author":"Appenzeller","year":"1992","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"2025020804504594600_bib6","doi-asserted-by":"publisher","first-page":"831730","DOI":"10.3389\/fcvm.2022.831730","article-title":"Association between cholinesterase inhibitors and new-onset heart failure in patients with Alzheimer's disease: a nationwide propensity score matching study","volume":"9","author":"Hsieh","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025020804504594600_bib7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/jad-140513","article-title":"Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature","volume":"42","author":"Femminella","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"2025020804504594600_bib8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025020804504594600_bib9","doi-asserted-by":"publisher","first-page":"C155","DOI":"10.1152\/ajpcell.00315.2020","article-title":"Protective and anti-inflammatory effects of acetylcholine in the heart","volume":"320","author":"Rocha-Resende","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"2025020804504594600_bib10","doi-asserted-by":"publisher","first-page":"e13396","DOI":"10.1111\/apha.13396","article-title":"The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: from cells to patient reports","volume":"228","author":"Khuanjing","year":"2020","journal-title":"Acta Physiol (Oxf)"},{"key":"2025020804504594600_bib11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"key":"2025020804504594600_bib12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","article-title":"Targeting the inflammasome in cardiovascular disease","volume":"7","author":"Olsen","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"2025020804504594600_bib13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1533317512442999","article-title":"Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?","volume":"27","author":"Isik","year":"2012","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2025020804504594600_bib14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.amjopharm.2010.09.001","article-title":"Evaluation of the effects of galantamine on cardiac function in elderly patients with Alzheimer's disease","volume":"8","author":"Isik","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"2025020804504594600_bib15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2169\/internalmedicine.51.6671","article-title":"Cardiac safety of donepezil in elderly patients with Alzheimer disease","volume":"51","author":"Isik","year":"2012","journal-title":"Intern Med"},{"key":"2025020804504594600_bib16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/1533317514536598","article-title":"Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?","volume":"29","author":"Isik","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2025020804504594600_bib17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"Abeta amyloid pathology affects the hearts of patients with Alzheimer's Disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025020804504594600_bib18","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/eurheartj\/eht131","article-title":"Circulating platelet-progenitor cell coaggregate formation is increased in patients with acute coronary syndromes and augments recruitment of CD34+ cells in the ischaemic microcirculation","volume":"34","author":"Stellos","year":"2013","journal-title":"Eur Heart J"},{"key":"2025020804504594600_bib19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.trci.2019.03.004","article-title":"The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: a review of recent clinical applications","volume":"5","author":"Eldufani","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"2025020804504594600_bib20","doi-asserted-by":"publisher","first-page":"e2220","DOI":"10.1212\/WNL.0000000000011832","article-title":"Long-term effects of cholinesterase inhibitors on cognitive decline and mortality","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology"},{"key":"2025020804504594600_bib21","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","article-title":"The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease","volume":"34","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Heart J"},{"key":"2025020804504594600_bib22","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/jgs.15415","article-title":"Cardiovascular outcomes of cholinesterase inhibitors in individuals with dementia: a meta-analysis and systematic review","volume":"66","author":"Isik","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"2025020804504594600_bib23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jalz.2018.02.011","article-title":"Acetylcholinesterase inhibitors and risk of stroke and death in people with dementia","volume":"14","author":"Tan","year":"2018","journal-title":"Alzheimers Dement"},{"key":"2025020804504594600_bib24","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000201161","article-title":"Effect of cholinesterase inhibitors on mortality in patients with dementia: a systematic review of randomized and nonrandomized trials","author":"Truong","year":"2022","journal-title":"Neurology"},{"key":"2025020804504594600_bib25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mayocp.2020.05.048","article-title":"The Association between the use of cholinesterase inhibitors and cardiovascular events among older patients with Alzheimer disease","volume":"96","author":"Hsiao","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2025020804504594600_bib26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.amjcard.2023.05.041","article-title":"Potential cardiologic protective effects of acetylcholinesterase inhibitors in patients with mild to moderate dementia","volume":"200","author":"Rampa","year":"2023","journal-title":"Am J Cardiol"},{"key":"2025020804504594600_bib27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/FJC.0b013e3182609a74","article-title":"Influences of donepezil on cardiovascular system\u2014possible therapeutic benefits for heart failure\u2014donepezil cardiac test registry (DOCTER) study","volume":"60","author":"Kubo","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025020804504594600_bib28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ejhf.222","article-title":"Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders","volume":"17","author":"Cermakova","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2025020804504594600_bib29","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/j.1532-5415.2009.02488.x","article-title":"Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system","volume":"57","author":"Hernandez","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"2025020804504594600_bib30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.kint.2022.09.022","article-title":"Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementia","volume":"103","author":"Xu","year":"2023","journal-title":"Kidney Int"},{"key":"2025020804504594600_bib31","doi-asserted-by":"publisher","first-page":"e2212476120","DOI":"10.1073\/pnas.2212476120","article-title":"Cholinergic regulation of vascular endothelial function by human ChAT(+) T cells","volume":"120","author":"Tarnawski","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025020804504594600_bib32","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nbt.3663","article-title":"Blood pressure regulation by CD4(+) lymphocytes expressing choline acetyltransferase","volume":"34","author":"Olofsson","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2025020804504594600_bib33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Invest"},{"key":"2025020804504594600_bib34","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1523\/JNEUROSCI.4558-10.2011","article-title":"Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic alpha7 nicotinic receptors","volume":"31","author":"Norman","year":"2011","journal-title":"J Neurosci"},{"key":"2025020804504594600_bib35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10557-020-07062-1","article-title":"Impact of peripheral \u03b17-nicotinic acetylcholine receptors on cardioprotective effects of Donepezil in chronic heart failure rats","volume":"35","author":"Li","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025020804504594600_bib36","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142945","article-title":"Alpha7 Nicotinic acetylcholine receptor mediates right ventricular fibrosis and diastolic dysfunction in pulmonary hypertension","volume":"6","author":"Vang","year":"2021","journal-title":"JCI Insight"},{"key":"2025020804504594600_bib37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156720510790274455","article-title":"Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer's disease: a review of recent clinical studies","volume":"7","author":"Darreh-Shori","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"2025020804504594600_bib38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1533317518775044","article-title":"The impact of a long-term rivastigmine and Donepezil treatment on all-cause mortality in patients with Alzheimer's disease","volume":"33","author":"Kazmierski","year":"2018","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2025020804504594600_bib39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"2025020804504594600_bib40","doi-asserted-by":"publisher","first-page":"e10613","DOI":"10.1016\/j.heliyon.2022.e10613","article-title":"Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer's disease treatment","volume":"8","author":"Uzairu","year":"2022","journal-title":"Heliyon"},{"key":"2025020804504594600_bib41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40262-013-0038-9","article-title":"Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease","volume":"52","author":"Noetzli","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"2025020804504594600_bib42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13195-016-0214-x","article-title":"Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study","volume":"8","author":"Hager","year":"2016","journal-title":"Alzheimers Res Ther"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcvp\/advance-article-pdf\/doi\/10.1093\/ehjcvp\/pvae091\/61371494\/pvae091.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/1\/22\/61371494\/pvae091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article-pdf\/11\/1\/22\/61371494\/pvae091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T23:52:19Z","timestamp":1738972339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/11\/1\/22\/7945205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,2,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvae091","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2025,1]]}}}